فهرس واحد لمناهج البحث — تعرّف على طريقة عمل كل منهج، ومتى يُستخدم، وما الذي لا يستطيع فعله.
The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is wide
The FACT-Ovarian (FACT-O) is a disease-specific quality-of-life measure for women with ovarian cancer, integrating the 27-item FACT-G core with a 12-item ovarian-specific subscale addressing cancer-related symptoms, sexual function, abdominal distension, and treatment side effects. Validated by Basen-Engquist et al. in
The FACT-Prostate (FACT-P) is a disease-specific quality-of-life instrument for men with prostate cancer, combining the 27-item FACT-G core with a 12-item prostate-specific subscale addressing urinary, sexual, and bowel function concerns. Developed and validated by Esper et al. in 1997, it is a standard outcome measure
The Frenchay Activities Index (FAI) is a self-report or informant-rated questionnaire designed to measure participation in activities of daily living and instrumental activities over a 3-month period. Developed by Holbrook and Skilbeck (1983) at the Frenchay Hospital in Bristol, the FAI evaluates participation in 15 ac
The Falls Efficacy Scale-International (FES-I), developed by Lucy Yardley and colleagues in 2005, is a validated tool measuring fear of falling and confidence in balance in older adults and others at risk of falls. The 16-item scale assesses how confident a person feels performing daily activities without falling (self
The Ford Insomnia Response to Stress Test (FIRST) is a brief self-report measure designed to identify individuals with heightened vulnerability to insomnia in response to psychological stress. Developed by Ford and Kamerow in 1990, it captures the tendency to experience sleep disruption during periods of worry, work pr
The FLACC Behavioral Pain Scale (Face, Legs, Activity, Cry, Consolability) is a 5-item observational tool developed by Merkel and Voepel-Lewis in 1997 to assess acute pain in children ages 2 months to 7 years who are unable to self-report pain. Each of the five behavioral domains is scored 0-2, yielding a total score o
The Functional Living Index-Cancer is a 22-item patient self-report instrument that measures health-related quality of life in cancer patients across physical, social, emotional, and overall QoL domains. Developed by Schipper and colleagues in the mid-1980s, the FLIC was among the first disease-specific QoL instruments
The Flow at Work Scale (derived from Csikszentmihalyi's flow theory and operationalized by Bakker as the Work-Related Flow Inventory) measures the degree to which employees experience 'flow'—a state of optimal absorption, focus, and enjoyment in work. Flow is characterized by full concentration, loss of self-consciousn
Flow cytometry is a laser-based technology for analyzing and sorting individual cells based on fluorescent markers. Developed by Leonard Herzenberg in the 1970s, flow cytometry enables rapid assessment of cell phenotype, drug effects on cell populations, and therapeutic cell characterization in immunology and hematolog
Fluid Balance Monitoring is a systematic nursing process for tracking and comparing fluid intake and output to maintain adequate hydration and detect abnormalities in fluid status. By measuring all sources of fluid intake (oral, intravenous, enteral feeding) and all routes of fluid loss (urine, feces, perspiration, dra
The Foot and Ankle Outcome Score (FAOS) is a 42-item patient self-report instrument designed to assess symptoms, function, and activity limitations in individuals with foot and ankle pathology. Developed by Roos and colleagues in 2001 and published in the Journal of Orthopedic & Sports Physical Therapy, the FAOS has be
The Fugl-Meyer Assessment (FMA) is a comprehensive, clinician-administered scale measuring sensorimotor recovery and motor impairment in stroke patients. Developed by Fugl-Meyer and colleagues in 1975, FMA has become the gold standard outcome measure in stroke rehabilitation research and clinical practice for quantifyi
Functional Behavioral Assessment (FBA) is a systematic process for identifying the environmental and behavioral factors that maintain or contribute to a target behavior. Developed by Richard O'Neill, Robert Horner, and colleagues in the 1990s, FBA is a cornerstone of applied behavior analysis and is widely used in educ
The Functional Independence Measure (FIM) is an 18-item standardized assessment of functional status and disability that measures the level of assistance required for activities of daily living (ADLs) and mobility in individuals with disabilities. Developed by Granger and Hamilton in the 1980s, the FIM has become a sta
The Functional Independence Measure (FIM) is a comprehensive 18-item scale assessing functional independence and burden of care in patients with disability across motor and cognitive domains. Developed by Granger and colleagues in 1987, FIM has become the standard outcome measure in rehabilitation medicine, mandated by
The General Health Questionnaire-12 (GHQ-12) is a brief, 12-item self-report screening instrument for psychological distress and mental health problems in the general population. Developed by David P. Goldberg, the GHQ-12 is the most widely used short form of the longer General Health Questionnaire series. It is design
The Generalized Anxiety Disorder-7 (GAD-7) is a brief, 7-item self-report instrument for screening and assessing the severity of anxiety symptoms in primary care and mental health settings. Developed by Spitzer and colleagues in 2006, the GAD-7 mirrors the structure and validation approach of the widely successful PHQ-
The GAD-7 is a brief 7-item self-report questionnaire designed to screen for and measure the severity of generalized anxiety disorder in adolescents and adults. Developed by Spitzer, Kroenke, Williams, and Löwe in 2006, it has become one of the most widely used anxiety screening tools in primary care, mental health res
The Geriatric Depression Scale (GDS) is a 30-item self-report depression screening instrument specifically designed for older adults. Developed by Yesavage, Brink, and colleagues in 1982, the GDS addresses the unique presentation of depression in aging populations, where symptoms may differ from younger adults. A valid
The Glasgow Coma Scale (GCS), developed by Teasdale and Jennett in 1974, is a 15-point scale used to assess level of consciousness and severity of brain injury. It evaluates eye opening, verbal response, and motor response, making it the gold standard tool for rapid neurological assessment in trauma, emergency, and int
The Glasgow-Blatchford score (GBS), developed by Blatchford et al. in 2000, is a 23-point risk stratification tool for predicting the need for intervention (transfusion, endoscopic therapy, surgery) in patients presenting with acute upper gastrointestinal bleeding. It integrates clinical and laboratory data to identify
The Global Rating of Change (GRC) Scale is a single-item, self-report outcome measure that asks patients to rate the overall change in their condition since baseline assessment. Developed by Jaeschke, Singer, and Guyatt in 1989 and published in Controlled Clinical Trials, the GRC Scale has become a fundamental method f
The Glasgow Sleep Effort Scale (GSES) is a brief instrument designed to measure the degree of mental and behavioral effort exerted in attempting to fall asleep. Developed by Broomfield and Espie in 2005, the GSES captures a key cognitive-behavioral maintenance mechanism in insomnia: excessive effort to sleep, anxiety a
The Hamilton Anxiety Rating Scale (HAM-A) is a clinician-administered assessment tool for quantifying the severity of anxiety symptoms in adults. Developed by Max Hamilton in 1959, it remains one of the most widely used instruments for evaluating anxiety in clinical and research settings. The scale measures both psycho
The Hamilton Depression Rating Scale, published by Max Hamilton in 1960, is a clinician-administered interview assessment of depressive symptom severity. The most common version contains 17 items (HAM-D-17), though 21-item and 24-item versions exist. It is considered the gold standard outcome measure in antidepressant
The Health Assessment Questionnaire Disability Index (HAQ-DI) is a 20-item self-report measure of functional disability developed by Fries and colleagues at Stanford University in 1980. Originally designed for rheumatoid arthritis, the HAQ-DI has become the gold-standard functional assessment instrument across diverse
The HD-QoL is a disease-specific quality-of-life instrument designed to measure the multidimensional impact of Huntington's disease on patients' physical, emotional, social, and cognitive functioning. Developed by Helder and colleagues in 2001, it uniquely addresses the progressive motor, cognitive, and psychiatric man
The Heart Failure Somatic Awareness Scale (HFSAS) is a specialized measure that assesses heart failure patients' ability to recognize and accurately perceive early warning signs of disease worsening (somatic awareness), such as subtle changes in dyspnea, edema, weight, fatigue, or palpitations. Early recognition of dec
The Helpful Aspects of Therapy (HAT) form is a semi-structured client feedback instrument designed to capture the client's perception of what was most beneficial or helpful in a therapy session or course of treatment. Developed by Llewellyn and refined by Elliott, the HAT combines open-ended narrative response with str
The Hill-Bone Compliance Scale (HBCS) is a brief, disease-specific self-report measure designed to assess medication and lifestyle adherence in hypertension management. Developed by Kim, Hill, Bone, and Levine at Johns Hopkins University in 1999, the HBCS measures three dimensions of hypertension adherence: medication-
The Hip Disability and Osteoarthritis Outcome Score (HOOS) is a patient-reported outcome measure developed to assess pain, symptoms, function, and quality of life in patients with hip osteoarthritis and hip disability. Developed by Nilsdotter and colleagues in 2003, HOOS parallels the structure of KOOS (Knee Injury and
The Hip Outcome Score (HOS) is a 29-item patient self-report instrument designed to measure symptoms, functional limitations, and activity restrictions in individuals with hip disorders. Originally developed and published by Philippon, Kelly, and Martin in 2006 in Arthroscopy, the HOS has become the standard outcome me
The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report instrument measuring anxiety and depression symptoms in medically ill populations. Developed by Zigmond and Snaith in 1983, the HADS was specifically designed for hospital and general medical settings where somatic symptoms of medical illness may
The Hyperarousal Scale is an assessment tool measuring elevated physiologic and cognitive activation during sleep and wakefulness in insomnia patients. Rooted in contemporary understanding of insomnia as a disorder of hyperarousal (excessive vigilance, elevated muscle tension, racing thoughts, heightened startle respon
The Hypoglycemia Fear Survey (HFS) is a self-report measure that quantifies fear of, anxiety about, and behavioral responses to hypoglycemia in patients with type 1 diabetes and insulin-treated type 2 diabetes. Originally developed by Cox and colleagues in 1987 and revised (HFS-II) in 1993, the HFS captures the emotion
The IAT is a 20-item self-report questionnaire designed to measure problematic internet use and internet addiction. Developed by Kimberly Young in 1998, it was one of the first validated screening tools for internet-related compulsive use. The IAT assesses loss of control, salience (preoccupation with internet), withdr
The IKDC Subjective Knee Form is an 18-item patient self-report instrument that measures knee function and symptoms in individuals with various knee conditions. Developed by the International Knee Documentation Committee in 2001 and published in the American Journal of Sports Medicine, it has become the gold standard f
The Impact on Participation and Autonomy (IPA) scale is a validated, patient-centered measure designed to quantify how chronic conditions or disabilities affect an individual's autonomy and participation in five key life domains: autonomy, mobility, occupation, social relations, and recreation. Developed in the Netherl
The IMAQ is a 26-item self-report instrument assessing healthcare professionals' attitudes toward integrative medicine—the combined use of conventional and complementary therapies based on evidence and patient-centered values. Developed by Bikker and colleagues, it measures five dimensions of attitudes: cognitive, prac
The Internalized Stigma of Mental Illness Scale (ISMI) is a 29-item self-report measure assessing the extent to which individuals with serious mental illness have internalized societal stigma—that is, adopted negative beliefs and stereotypes about themselves and their condition. Developed by Ritsher, Otilingam, and Gra
The International Physical Activity Questionnaire (IPAQ) is a standardized self-report measure of physical activity developed by the International Society for Physical Activity and Health in 2003. Available in short (7 items) and long (31 items) forms, it assesses moderate-to-vigorous and light physical activity across
Interpersonal Therapy (IPT) assessment is a structured evaluation of the client's current symptoms and their interpersonal context to identify one or more core interpersonal problems (grief, disputes, role transitions, or interpersonal deficits) maintaining the client's psychological distress. Developed by Gerald Klerm
The IUS-12 is a 12-item self-report measure of intolerance of uncertainty, a cognitive vulnerability factor underlying anxiety across multiple disorders. Developed by Carleton, Norton, and Asmundson in 2007 as short form of the original IUS-27, it measures difficulty accepting or managing uncertainty and associated anx
The IRLS is a 10-item clinician-administered rating scale designed to assess the severity of symptoms in patients with restless legs syndrome (RLS). Developed and validated by Walters and colleagues in 2003 for the International Restless Legs Syndrome Study Group, it is the most widely used disease-specific severity me
Isobologram analysis is a graphical and quantitative method for detecting and classifying drug interactions, developed by Salvatore Loewe in 1926. It uses dose-response data from two drugs applied individually and in combination to determine whether their interaction is additive, synergistic, or antagonistic.
The ITQOL is a generic parent-report instrument developed by Landgraf et al. in 1997 to measure health-related quality of life in infants and toddlers aged 2 months to 5 years. Addressing the developmental uniqueness of the very young, the ITQOL captures health-related functioning across domains relevant to early child
The JAFAR is a parent-report instrument developed by Lovell et al. in 1989 to assess functional ability in children and adolescents with juvenile idiopathic arthritis (JIA). Measuring across multiple domains including lower extremity function, upper extremity function, and activities of daily living, the JAFAR quantifi
The Jebsen-Taylor Hand Function Test (JHFT) is a standardized, performance-based measure of hand function developed to provide an objective, quantitative assessment of manual dexterity and hand capability. Created by Jebsen and colleagues (1969) at the University of Minnesota, the JHFT consists of seven timed functiona
The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item, multidimensional self-report measure that evaluates heart failure-related symptoms, functional limitations, and quality of life in patients with cardiomyopathy and heart failure of all severities. Developed by Spertus and colleagues in 2000, the KCCQ pro
The Katz Index of Independence in Activities of Daily Living, developed by Sidney Katz and colleagues in 1963, is one of the earliest and most widely used tools for assessing functional status in older adults and persons with chronic illness. The scale evaluates six essential self-care activities (bathing, dressing, to
The Kessler Psychological Distress Scale-10 (K10) is a 10-item self-report measure of non-specific psychological distress and mental health problems. Developed by Kessler and colleagues in 2002, the K10 was designed as an ultra-brief screening instrument for population surveys and epidemiological research. A shorter 6-
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a patient-reported outcome measure designed for active patients with knee injury and osteoarthritis. Developed by Roos and colleagues in 1998, KOOS extends assessment beyond traditional osteoarthritis scales to include symptoms, pain, function in daily living,
The LANSS is a brief seven-item hybrid screening and diagnostic tool designed to differentiate neuropathic pain from non-neuropathic (nociceptive) pain. Developed by Mark Bennett at the University of Leeds in 2001, it combines five patient-reported symptom items with two clinician-performed neurological examination fin
The Lawton-Brody Instrumental Activities of Daily Living (IADL) Scale, developed by M. Powell Lawton and Elaine M. Brody in 1969, measures the capacity to perform complex, higher-order self-care and household tasks necessary for independent community living. The scale assesses eight domains (for women) or five domains
The Liebowitz Social Anxiety Scale (LSAS) is a 24-item clinician-administered scale designed to measure the severity of social anxiety and avoidance in individuals with social anxiety disorder. Developed by Michael R. Liebowitz in 1987, the LSAS has become the gold-standard instrument for assessing social phobia in cli
The Link Stigma Scale, also called the Perceived Devaluation-Discrimination Scale, is a measure of perceived stigma developed by Bruce G. Link in 1987. It assesses the extent to which individuals with serious mental illness perceive that society devalues people with mental illness and discriminates against them. Unlike
Liposomal encapsulation is a formulation technique using lipid bilayer vesicles (liposomes) to enclose drugs, improving bioavailability, reducing toxicity, and enabling targeted delivery. Developed by Alec Bangham in 1965, liposomes are now standard in pharmaceutical development, with several FDA-approved liposomal dru
The Lower Extremity Functional Scale (LEFS) is a 20-item patient self-report instrument designed to assess functional limitations in individuals with lower extremity musculoskeletal disorders. Developed by Binkley, Stratford, Lott, and Riddle in 1999 and published in Physical Therapy, the LEFS provides a validated, gen
The Lysholm Knee Scoring Scale is an 8-item knee outcome instrument developed by Swedish orthopedic surgeons Lysholm and Gillquist in 1982 to evaluate knee ligament surgery results. Published in the American Journal of Sports Medicine, the Lysholm Scale was among the first validated knee outcome measures and remains wi